Complex formation between the vasopressin 1b receptor, β-arrestin-2, and the μ-opioid receptor underlies morphine

Taka-Aki Koshimizu1, Kenji Honda2, Sachi Nagaoka-Uozumi2

  • 1Department of Pharmacology, Division of Molecular Pharmacology, Jichi Medical University, Shimotsuke, Tochigi, Japan. t_koshi@jichi.ac.jp.

Insights

Blocking vasopressin 1b receptors (V1bRs) delays morphine tolerance by preventing receptor complex formation. This approach enhances morphine analgesia without increasing tolerance, offering a new therapeutic strategy.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Chronic morphine use leads to opioid tolerance, reducing pain relief.
  • The mechanisms by which nonopioid neurotransmitters influence opioid tolerance are not fully understood.

Purpose of the Study:

  • To investigate the role of vasopressin 1b receptors (V1bRs) in the development of morphine tolerance.
  • To elucidate the molecular mechanisms underlying V1bR involvement in opioid tolerance.

Main Methods:

  • Utilized knockout mice lacking V1bRs and pharmacological antagonism of V1bRs in the rostral ventromedial medulla.
  • Examined V1bR and μ-opioid receptor (MOR) co-localization and interactions using cell-based assays.
  • Investigated the role of β-arrestin-2 and ERK phosphorylation in vasopressin-mediated signaling.

Main Results:

  • Morphine tolerance was delayed in V1bR-deficient mice and upon V1bR antagonist administration.
  • Vasopressin enhanced morphine-binding affinity to cells co-expressing V1bR and MOR.
  • V1bR, β-arrestin-2, and MOR complex formation mediated vasopressin-induced ERK phosphorylation and adenylate cyclase sensitization.
  • A specific leucine-rich segment in V1bR was crucial for β-arrestin-2 association.

Conclusions:

  • Inhibition of μ-opioid-receptor-associated V1bR is a viable strategy to enhance morphine analgesia.
  • Targeting V1bR signaling can mitigate the development of analgesic tolerance.
  • This research offers a novel therapeutic avenue for improving opioid pain management.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.6K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.1K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.9K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.3K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
111.3K